Intravesical BCG for bladder cancer: how much is enough?14-3-3 sigmathyroidcancerhypermethylationNo abstract is available for this article.doi:10.1002/cncr.23628Ashish M. KamatJohn Wiley & Sons, Ltd.Cancer
aEffect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: A systematic review. 抗凝剂和antiplatelet代理的作用在膀胱癌的intravesical BCG治疗效力: 系统的回顾。[translate] aFAT Attributes 油脂属性[translate] ...
The BCG shortage: No short-term solution! Adele M. Caruso, DNP, CRNP, FAANP "Bacillus Calmette-Guerin (BCG) intravesical immunotherapy is the most effective treatment for management of our patients with non-muscle invasive bladder cancer. What do we do without it, and how do we explain the...
, non-muscle invasive bladder cancer [NMIBC]) and when your tumor is a type called “carcinoma in situ” (CIS), and you have tried treatment with Bacillus Calmette-Guerin (BCG) and it did not work, and you are not able to or have decided not to have surgery to remove your bladder....
high-risk, non-muscle invasive bladder cancer [NMIBC])and when your tumor is a type called “carcinoma in situ” (CIS),andyou have tried treatment with Bacillus Calmette-Guerin (BCG) and it did not work,andyou are not able to or have decided not to have surgery to remove your bladder...
Pepto-Bismol is a commonly used medication to help alleviate symptoms of an upset stomach,diarrhea, nausea, heartburn, and indigestion. It is an over-the-counter medication and does not require a prescription from a doctor. Pepto-Bismol is considered an effective option that works to treat mild...
Treatment vaccines- BCG This type of immunotherapy for cancer is also known as Bacillus Calmette Guerin is considered as the most popular treatment vaccine that works against cancer as it boosts the responseof the immune system to the cancer cells as it is a weakened form of bacteriathat is kn...
Intravesical therapy for non-muscle invasive bladder cancer decreases recurrence and progression but carries a high risk of side effects, which limit patient adherence. Appropriate management of the toxicities from intravesical therapy requires consideration of the agent used, the side effects experienced,...
Intravesical therapy remains the mainstay of treatment for NMIBC and bladder preservation. Intravesical induction BCG followed by maintenance therapy remains standard of care for intermediate and high-risk patients. Detailing the timing and characteristics of recurrence after intravesical therapy is crucial ...
maintenance BCGBACKGROUND.Intravesical bacillus Calmette-Gu茅rin (BCG) immunotherapy is effective in preventing recurrence and progression in nonmuscle-invasive bladder cancer but the dosing schedule and duration of treatment remain empirical. The outcome of BCG therapy was prospectively evaluated on ...